Cite
HARVARD Citation
Chatzidionysiou, K. et al. (2016). A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission. RMD open. 2 (1), p. . [Online].